{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:50:03Z","timestamp":1760575803592,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jfma.2021.01.003","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:59:50Z","timestamp":1611104390000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["The prevalence and clinical features of chronic obstructive pulmonary disease patients with traits of asthma in Taiwan"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-5899","authenticated-orcid":false,"given":"Wei-Chang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diahn-Warng","family":"Perng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Chien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Lung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben Cheng-Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.01.003_bib1","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/gheg.2018.1","article-title":"The unmet global burden of COPD","volume":"3","author":"Quaderi","year":"2018","journal-title":"Global Health, Epidemiology and Genomics"},{"key":"10.1016\/j.jfma.2021.01.003_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet (London, England)"},{"year":"2014","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Updated 2014","key":"10.1016\/j.jfma.2021.01.003_bib3"},{"article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2020 report","year":"2020","series-title":"The global initiative for chronic obstructive lung disease-GOLD","key":"10.1016\/j.jfma.2021.01.003_bib4"},{"key":"10.1016\/j.jfma.2021.01.003_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes: the future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2021.01.003_bib6","first-page":"S146","article-title":"Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review","volume":"6","author":"Papaiwannou","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jfma.2021.01.003_bib7","first-page":"1729","article-title":"[Guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 3rd edition]","volume":"69","author":"Nagai","year":"2011","journal-title":"Nihon rinsho Japanese J of clinical Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arbres.2012.04.001","article-title":"Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish society of pulmonology and thoracic surgery","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jfma.2021.01.003_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.arbres.2011.12.009","article-title":"Consensus document on the overlap phenotype COPD-asthma in COPD","volume":"48","author":"Soler-Catalu\u00f1a","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jfma.2021.01.003_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.00216013","article-title":"The clinical and genetic features of COPD-asthma overlap syndrome","volume":"44","author":"Hardin","year":"2014","journal-title":"Eur Respir J"},{"year":"2016","series-title":"Diagnosis of diseases of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome","key":"10.1016\/j.jfma.2021.01.003_bib11"},{"article-title":"Global strategy for asthma management and prevention","year":"2020","series-title":"(2020 updated): Global initiative for asthma-GINA","key":"10.1016\/j.jfma.2021.01.003_bib12"},{"year":"2017","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 report","key":"10.1016\/j.jfma.2021.01.003_bib13"},{"key":"10.1016\/j.jfma.2021.01.003_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: selection of reference values and interpretative strategies","volume":"144","year":"1991","journal-title":"American Thoracic Society, The American review of respiratory disease"},{"key":"10.1016\/j.jfma.2021.01.003_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"The Lancet Respiratory Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib17","first-page":"1143","article-title":"Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices","volume":"16","author":"Krishnan","year":"2019"},{"key":"10.1016\/j.jfma.2021.01.003_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/COPD.S133859","article-title":"Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach","volume":"12","author":"Inoue","year":"2017","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.jfma.2021.01.003_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/all.13004","article-title":"Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?","volume":"72","author":"Caillaud","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jfma.2021.01.003_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00506-2017","article-title":"Diagnosis of asthma-COPD overlap: the five commandments","volume":"49","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jfma.2021.01.003_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/ecp.13.2","article-title":"The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations","volume":"6","author":"Louie","year":"2013","journal-title":"Expet Rev Clin Pharmacol"},{"volume":"vol. 49","year":"2017","author":"Miravitlles","key":"10.1016\/j.jfma.2021.01.003_bib22"},{"key":"10.1016\/j.jfma.2021.01.003_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12931-014-0130-1","article-title":"The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function","volume":"15","author":"Jin","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.jfma.2021.01.003_bib25","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"The Lancet Respiratory medicine"},{"key":"10.1016\/j.jfma.2021.01.003_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/ajrccm.151.2.7842192","article-title":"Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group","volume":"151","author":"Kerstjens","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib28","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol\u2013glycopyrronium versus salmeterol\u2013fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2021.01.003_bib29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jfma.2021.01.003_bib30","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1097\/MD.0000000000000755","article-title":"Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients: a population-based cohort study","volume":"94","author":"Chung","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jfma.2021.01.003_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136065","article-title":"Asthma and COPD overlap syndrome (acos): a systematic review and meta analysis","volume":"10","author":"Alshabanat","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2021.01.003_bib32","doi-asserted-by":"crossref","first-page":"j3772","DOI":"10.1136\/bmj.j3772","article-title":"Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets","volume":"358","author":"Leung","year":"2017","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.jfma.2021.01.003_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1378\/chest.13-0622","article-title":"Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma","volume":"145","author":"Menezes","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jfma.2021.01.003_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12890-017-0571-7","article-title":"Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study","volume":"18","author":"Shantakumar","year":"2018","journal-title":"BMC Pulm Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:47:11Z","timestamp":1760539631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0929664621000206"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.01.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence and clinical features of chronic obstructive pulmonary disease patients with traits of asthma in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}